Metabolic programs drive function of therapeutic NK cells in hypoxic tumor environmentsPhilippa R Kennedy, Martin Felices, Quinlan M. Kile et al.|Science Advances|2024Cited by 45
Novel trispecific killer engager targeting B7-H3 enhances natural killer cell antitumor activity against head and neck cancerMelissa Khaw, Jeffrey S. Miller, Nicholas A. Zorko et al.|Journal for ImmunoTherapy of Cancer|2025Cited by 8
Abstract 1241: Enhancing NK cell therapy for head and neck cancer within the solid tumor microenvironment using a B7H3-targeting tri-specific killer engager (TriKE)Melissa Khaw, Jeffrey S. Miller, Nicholas A. Zorko et al.|Cancer Research|2024Cited by 0